Tag: atricure
First patient treated in HEAL-IST clinical trial
AtriCure has announced that the first patient has been treated in the HEAL-IST trial, evaluating the safety and effectiveness of AtriCure’s Isolator Synergy Clamp...
CONVERGE IDE trial results presented at HRS 2020 Science
AtriCure has announced results from the CONVERGE IDE clinical trial, which showed an 18% difference in favour of the hybrid Convergent procedure as compared...
AtriCure announces completion of enrolment for aMAZE clinical trial
AtriCure has announced the successful completion of patient enrolment in the aMAZE clinical trial. In addition, the company announced that it has received approval...
AtriCure agrees to buy LARIAT developer SentreHEART
AtriCure has entered into a definitive agreement to acquire SentreHEART, which developed the LARIAT device for left atrial appendage closure in patients with atrial...
AtriCure receives clearance for expanded labelling claims for AtriClip devices
AtriCure has received US Food and Drug Administration (FDA) 510(k) clearance of additional labelling claims for AtriClip LAA management devices, including changing the indication...
AtriCure enters into definitive agreement to acquire SentreHeart
AtriCure has revealed that it has entered into a definitive agreement to acquire SentreHeart. Under the terms of the acquisition agreement, the transaction consideration...
First patient enrolled in ICE-AFIB clinical trial
A press release reports that the first patient has been enrolled in the ICE-AFIB clinical trial (AtriCure). Following Investigational Device Exemption (IDE) approval by...
CONVERGE IDE clinical trial completes enrolment
Atricure have announced that the enrolment of the full cohort of 153 patients in the CONVERGE IDE clinical trial has been completed. CONVERGE IDE is...
AtriClip Pro•V device launched onto US market
AtriCure has launched its AtriClip Pro•V left atrial appendage exclusion system in the USA. A press release reports that the new device offers an...
AtriCure names US principal investigator for the CONVERGE IDE clinical trial
AtriCure has announced David B DeLurgio as the US principal investigator for the CONVERGE IDE clinical trial.
DeLurgio is a cardiac electrophysiologist at Emory Healthcare in Atlanta, USA. He is...
AtriCure announces approval for the cryoICE platform in Japan
AtriCure has announced that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for its cryoICE platform and CRYO2 cryoablation probe....